Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bruce Cree, MD, PHD
University of California, San Francisco
Principal Investigator - Frederic Sedel, MD, PHD
Medday Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brain and Mind Centre/university of Sydney
Sydney, New South Wales, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- the Royal Melbourne Hospital
Parkville, Victoria, Australia
- Uz Antwerpen
Edegem, Antwerpen, Belgium
- Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, Limburg, Belgium
- Uz Gent
Halle, Oost-Vlaanderen, Belgium
- Burnaby Hospital
Burnaby, British Columbia, Canada
- Vancouver Hospital and Health Sciences Centre
Vancouver, British Columbia, Canada
- Hôpital Universitaire Dr George L-Dumont University Hospital
Moncton, New Brunswick, Canada
- Nova Scotia Rehabilitation Center
Halifax, Nova Scotia, Canada
- Ottawa Hospital General Campus
Ottawa, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Hopital de Notre Dame
Montreal, Quebec, Canada
- Montreal Neurologic Institute
Montreal, Quebec, Canada
- Doc. Mudr. Radomir Talab, Csc., Neurologie
Hradec Králové, Czechia
- Nemocnice Jihlava
Jihlava, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Nemocnice Teplice
Teplice, Czechia
- Universitätsklinikum Leipzig A.Ö.R. - Klinik Und Poliklinik
Leipzig, Saxony, Germany
- Fachkrankenhaus Hubertusburg
Wermsdorf, Saxony, Germany
- Caritas Krankenhaus
Bad Mergentheim, Germany
- Charité - Universitätsmedizin Berlin / Neurocure Clinical Research Center
Berlin, Germany
- Heinrich-Heine-Universität Düsseldorf
Düsseldorf, Germany
- Neuro Centrum Science Gmbh
Erbach im Odenwald, Germany
- Multipel Studies Institut Für Klinische Studien Gbr
Hamburg, Germany
- Ludwig-Maximilians Universität München
München, Germany
- Neuropoint Gmbh
Ulm, Germany
- Poliklinik Für Neurologie Universitätsklinikum Ulm
Ulm, Germany
- Valeomed Kft
Esztergom, Hungary
- Ospedale San Raffaele, Irccs
Milan, Italy
- Ao S.Andrea, Università Degli Studi Di Roma la Sapienza
Roma, Italy
- Nasz Lekarz Ośrodek Badań Klinicznych
Bydgoszcz, Poland
- Copernicus Pl Sp Z O.O.,szpital Im. M.Kopernika Oddział Neurologiczny
Gdansk, Poland
- Twoja Przychodnia Centrum Medyczne Nowa Sol
Nowa Sól, Poland
- Centrum Medyczne Pratia Warszawa
Warsaw, Poland
- Hospital Santa Caterina
Salt, Girona, Spain
- Hostipal Universitario Quirónsalud Madrid
Pozuelo de Alarcón, Madrid, Spain
- Servicio de Neurología Hospital Vithas Nisa Aljarafe
Castilleja de la Cuesta, Sevilla, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2016
- Primary completion
- 15 Nov 2019
- Completion
- 23 Apr 2020
- Last update posted
- 23 Nov 2020
- Registered enrollment
- 642
- Registry id
- NCT02936037
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.